Concepedia

Marco Ruella

MR

Statistics

Publications

88

Citations

10.7K

H-Index

41

Active since

2009

Affiliations

University of Pennsylvania(Current)

Children's Hospital of Philadelphia

Parker Institute for Cancer Immunotherapy

UPMC Hillman Cancer Center

Hospital of the University of Pennsylvania

Marco Ruella is an author at University of Pennsylvania specializing in immunotherapy, life sciences, and cancer immunotherapy.

ORCID

Publications per year

2009–2025

88

Publications

88

Human chimeric antigen receptor macrophages for cancer immunotherapy

Michael Klichinsky, Marco Ruella, Olga Shestova et al. · Nature Biotechnology · 2020 · 1.4K citations · Full text

, , +14

Convergence of Acquired Mutations and Alternative Splicing of <i>CD19</i> Enables Resistance to CART-19 Immunotherapy

Elena Sotillo, David M. Barrett, Kathryn L. Black et al. · Cancer Discovery · 2015 · 1.3K citations · Full text

, , +15

Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell

Marco Ruella, Jun Xu, David M. Barrett et al. · Nature Medicine · 2018 · 645 citations · Full text

, , +12

Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies

Marco Ruella, David M. Barrett, Saad S. Kenderian et al. · Journal of Clinical Investigation · 2016 · 555 citations · Full text

, , +16

Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor–modified T cells

Saar Gill, Sarah K. Tasian, Marco Ruella et al. · Blood · 2014 · 491 citations · Full text

, , +17

1–5 of 88